Navigation Links
Brookdale Announces Completion of Follow-On Offering
Date:6/8/2009

NASHVILLE, Tenn., June 8 /PRNewswire-FirstCall/ -- Brookdale Senior Living Inc. (NYSE: BKD) (the "Company") today announced the closing of its previously disclosed public offering of 13,953,489 shares of common stock, at a public offering price of $10.75 per share. The underwriters in the offering exercised in full their option to purchase 2,093,023 additional shares of common stock from the Company at the public offering price, resulting in net proceeds to the Company from the offering of approximately $164 million.

The Company has used a portion of the net proceeds from the offering to repay the $125 million of indebtedness that was outstanding under its credit agreement, and will use the remainder for working capital and other general corporate purposes.

As previously announced, in conjunction with the offering and at the Company's request, the Company's credit agreement was recently amended to, among other things, reduce the maximum revolving loan commitment to $75 million, eliminate the requirement for mandatory prepayments, and increase the Company's flexibility to make acquisitions and capital expenditures and to incur letters of credit and other liens.

Goldman, Sachs & Co., Barclays Capital Inc. and Merrill Lynch & Co. acted as Joint Book-Running Managers and as representatives for the underwriters of this offering.

The shares of common stock were offered and sold pursuant to a prospectus supplement, dated June 2, 2009, and related prospectus, dated May 22, 2009, each filed with the Securities and Exchange Commission.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlaw
'/>"/>

SOURCE Brookdale Senior Living Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Brookdale to Present at JMP Securities Research Conference
2. Brookdale to Present at Bank of America and Merrill Lynch 2009 Health Care Conference
3. Brookdale Announces First Quarter 2009 Results; CFFO of $0.49 per Share
4. Brookdale Announces First Quarter 2009 Release and Earnings Call
5. Brookdale to Present at Barclays Capital Global Healthcare Conference March 11
6. Brookdale Announces Fourth Quarter and Full Year 2008 Results
7. Brookdale Amends and Extends Corporate Line of Credit
8. Brookdale Announces Fourth Quarter 2008 Release and Earnings Call
9. Brookdale to Present at UBS Global Healthcare Services Conference February 10
10. AT&T Mobility and Brookdale Senior Living Host First Cell Phones for Seniors Public Service Event in New York City
11. Brookdale Announces Second Quarter 2008 Release and Earnings Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... MD, April 22, 2014: The Association for Molecular ... The Journal of Molecular Diagnostics on recommendations ... baccalaureate and master,s levels of education. The report ... Curriculum Task Force of the AMP Training and ... critical need of educating future medical laboratory scientists ...
(Date:4/22/2014)... German . ... but their mode of action is complex: In low ... behavior, while at high concentrations they can cause "oxidative ... how redox signaling unfolds in single cells and organelles ... developed jointly by the teams of LMU Professor Martin ...
(Date:4/22/2014)... we all seem to know who we say is neurotic ... isn,t unable to act but simply doesn,t want to., ... study of nearly 4,000 college students in 19 countries has ... decisions and moving forward with life. Turns out that when ... just don,t like it as much as non-neurotics. Therefore persuasive ...
(Date:4/22/2014)... This news release is available in German . ... F. Perutz Laboratories of the University of Vienna and the ... Zurich, have now shown how double stranded RNA, such as ... a cell. During the immune response against viral infection, the ... cytoplasm. There it modifies viral RNA to inhibit reproduction of ...
(Date:4/22/2014)... like toddlers, but their total brain size suggests ... or fox squirrel, according to a new study ... from orangutans to zebra finches. , Scientists at ... than two-dozen other research institutions collaborated on this ... defined in the study as the ability to ...
Breaking Medicine News(10 mins):Health News:AMP publishes curriculum recommendations for medical laboratory scientists 2Health News:Neuroimaging: Live from inside the cell 2Health News:Neurotics don't just avoid action: They dislike it 2Health News:How the body fights against viruses 2Health News:How the body fights against viruses 3Health News:Brain size matters when it comes to animal self-control 2Health News:Brain size matters when it comes to animal self-control 3
... MedCom USA, Inc.,(OTC Bulletin Board: EMED), a leading ... for the healthcare industry,has signed a distribution agreement ... force, the product line of MedCom USA.,MedCom,s products ... options which include Credit/Debit, Easy Pay and Check,Guarantee/EFT ...
... Heart Association says high blood sugar condition linked to ... -- A national effort is needed to deal with ... says an American Heart Association scientific statement released Monday. ... about the condition, also known as hyperglycemia, in people ...
... Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced ... president of clinical research. In this newly,created position, ... and,oversight of Rigel,s clinical research programs in rheumatoid ... syk kinase,inhibitor, is expected to enter advanced Phase ...
... /Xinhua-PRNewswire-FirstCall/ -- Lotus,Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS; ... the United States that operates Beijing Liang,Fang Pharmaceutical ... Pharmaceutical,Co., Ltd. both of which are pharmaceutical companies ... that it has raised $5 million in,a private ...
... NEW YORK, Feb. 26 , WHO: New York Lt. Gov. David A. Paterson, along with stem ... R. Lyon, M.D., will be the keynote speakers at the 3rd ... p.m. on Tuesday, February 26 ... Trianon Ballroom 1335 Avenue ...
... BMR, TORONTO, Feb. 26 /PRNewswire-FirstCall/ ... dedicated to the development and,commercialization of ... II data,on the Company,s Neuradiab product ... glioblastoma multiforme (GBM) were published in ...
Cached Medicine News:Health News:MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System 2Health News:MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System 3Health News:MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System 4Health News:National Effort Needed to Address Hyperglycemia in Heart Patients 2Health News:Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research 2Health News:Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research 3Health News:Lotus Pharmaceuticals Raises $5 Million in Private Placement 2Health News:Lotus Pharmaceuticals Raises $5 Million in Private Placement 3Health News:MEDIA ADVISORY: New York Lt. Gov. David Paterson and Stem Cell Experts to Participate in 3rd Annual Stem Cell Summit 2Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 2Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 3Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 4
(Date:1/15/2014)... is very pleased to announce the appointment of Mr. ... Mark was promoted from his current role of Chief Operating ... in Massachusetts , Mississippi ... 2012 with 20+ years of broad-based operations, sales, engineering and ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... developing its Symphony® CGM System as a non-invasive, wireless ... F. Doman , Executive Chairman and Interim CEO of ... Markets, Tenth Annual Equity Conference. Mr. ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... Ga., May 3, 2011 Precyse , ... and technologies, announces the general availability of ... information management platform available today. PrecyseCode is driven ... voice, converting it to text and transforming it ...
... May 3, 2011 HistoRx, Inc., announced today ... researchers interested in using AQUA® technology.  HistoRx,s proprietary ... biomarkers, including measurement of protein concentration with sub-cellular ... microarrays.  These highly quantitative, standardized and reproducible results ...
Cached Medicine Technology:Precyse Announces Commercial Release of Revolutionary Intelligent Workflow Solution for Health Information Management 2Precyse Announces Commercial Release of Revolutionary Intelligent Workflow Solution for Health Information Management 3Precyse Announces Commercial Release of Revolutionary Intelligent Workflow Solution for Health Information Management 4Precyse Announces Commercial Release of Revolutionary Intelligent Workflow Solution for Health Information Management 5Precyse Announces Commercial Release of Revolutionary Intelligent Workflow Solution for Health Information Management 6HistoRx Announces Launch of New Research Services: AQUAPrep™ and Access AQUA® Services Now Available 2HistoRx Announces Launch of New Research Services: AQUAPrep™ and Access AQUA® Services Now Available 3
... The VersaPulse® PowerSuite™ holmium laser combines ... for precise, virtually bloodless procedures. It ... urinary and gall bladder stones of ... multipurpose surgical tool. Because its laser ...
... laser combines excellent cutting, ablation and ... procedures. It is also extremely effective ... stones of all compositions, making it ... its laser light is transmitted through ...
... adjustable height permits optimal leg position for the ... a cast with the foot/ankle at 90 degrees ... the tongue of the stand. Stockinette is pulled ... plaster/fiberglass is used in a routine fashion. The ...
... Techno-Aide provides the highest level of ... quality lead protective eyewear. Consistent ... tolerance allowed. Mfg supervised by Licensed ... lens meet or exceed standards for ...
Medicine Products: